Omega Fund Management, LLC
Annual return '25
+65.2%
SPY '25
+17.7%
Alpha
+47.4ptsvs SPY
Invested
$163.1M
Holdings
10
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$BCAX
Bicara Therapeutics Inc.
Held since at least Q1 2024
29.2%
02
$NUVB
Nuvation Bio Inc.
Held since at least Q1 2024
21.2%
03
$BBOT
BridgeBio Oncology Therapeutics Inc.
Held since at least Q1 2024
18.0%
04
$KMTS
Kestra Med Technologies Ltd
Held since at least Q1 2024
12.5%
05
$BBNX
Beta Bionics Inc.
Held since at least Q1 2024
8.1%
06
$ENGN
enGene Holdings Inc.
Held since at least Q1 2024
3.7%
07
$ALMS
Alumis Inc.
Held since at least Q1 2024
3.3%
08
$SANA
Sana Biotechnology, Inc.
Held since at least Q1 2024
1.5%
09
$IMA
ImageneBio, Inc.
Held since at least Q1 2024
1.4%
10
$REPL
Replimune Group
Held since at least Q1 2024
1.2%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 09:26 UTC.